ANDA 201509, held by Ph Health. Zolpidem Tartrate.
As of Nov 16, 2026, ANDA 201509 (Zolpidem Tartrate), held by Ph Health, was first approved by FDA on Aug 1, 2016, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 1, 2016 | Original application | Approved | None posted |
| Zolpidem Tartrate5MG · tablet;sublingual | Zolpidem Tartrate | Rx |
| Zolpidem Tartrate10MG · tablet;sublingual | Zolpidem Tartrate | Rx |
| Nov 15, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Nov 15, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Aug 1, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters